Frontlight ResearchEarly access
Trial site
MD Anderson Cancer Center at Cooper
- 7running trials
- 6closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Melanoma3 trials
- Ovarian cancer3 trials
- Cervical cancer2 trials
- Bladder cancer1 trial
- Brain metastases1 trial
- Childhood cancers1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- and 3 more
- Phase
- Phase 37 trials
- Phase 1/22 trials
- Phase 22 trials
- Phase 41 trial
- Status
- Active, not recruiting3 trials
- Completed3 trials
- Recruiting3 trials
- Withdrawn2 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Agenus Inc.1 trial
- Cooper Norcross Health1 trial
- Eisai Inc.1 trial
- Genmab1 trial
- Hoffmann-La Roche1 trial
- and 8 more
Running trials
Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Melanoma2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
Closed trials
Recruiting
Recruiting
Recruiting
Completed
Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian
Terminated
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026